About
CEVR Team
Careers
Read for the Registry
Contact Us
News & Events
News
Events
Publications
Databases
CEA Registry
GH CEA Registry
SPEC Database
Sponsorship
Sponsor login
Contact Us
News & Events
News
2023 CEA Registry Remote Summer Fellowship
What is CEVR and the CEA Registry? CEVR is a leading research center on issues pertaining to value, cost-effectiveness, and risk tradeoffs in healthca...
How might US health plans cover AMX0035 (Relvyrio™) for ALS? Lessons from the SPEC Database
How might US health plans cover AMX0035 (Relvyrio™) for ALS? Lessons from the SPEC Database By Molly Beinfeld and James Chambers In what is a sign...
Use of “Novel” Elements of Value in Cost-Effectiveness Analyses
By: Elliott Crummer, MA, Joshua Cohen, PhD, Peter Neumann, ScD Introduction In 2018 an ISPOR Special Task Force (STF) argued that conventional cost...
View All News Items
Events
Seminar with Brian D Smith, BSc, DipM PhD FRSA
Health Policy Seminar with Hadley Stevens Smith, PhD, MPSA
Virtual Health Policy Seminar with Nancy Keating, MD, MPH
View All Events
Publications
Medicare Coverage of Emerging Technologies: Challenges and Opportunities
Pharmacoeconomics
Engaging patients and caregivers in an early health economic evaluation: Discerning treatment value based on lived experience
Health Affairs
State-level variation in low-value care for commercially insured and Medicare Advantage populations
Clinical Therapeutics
Incentivizing drug development in serious mental illness
Journal of Managed Care and Specialty Pharmacy
Characterizing health plan evidence review practices
Medical Care
Effect of the 2012 US Preventive Services Task Force recommendations on prostate-specific antigen screening in a Medicare advantage population
Applied Health Economics and Health Policy
Family spillover effects: Are economic evaluations misrepresenting the value of healthcare interventions to society?
Alzheimer's & Dementia
Alzheimer's disease medication use and adherence patterns by race and ethnicity
Journal of Managed Care & Specialty Pharmacy
When are breakthrough therapies cost-effective?
View All Publications
